Liposomal drug delivery
1996; Elsevier BV; Volume: 1; Issue: 5 Linguagem: Inglês
10.1016/s1359-0294(96)80103-8
ISSN1879-0399
Autores Tópico(s)RNA Interference and Gene Delivery
ResumoRecently, liposomal drug delivery systems have come of age, with three antifungal and two anticancer preparations having received final approval for clinical use in a number of countries around the world. A number of other liposomal formulations of drugs, including anticancer, antibacterial and anti-inflammatory drugs, are in early-to-late clinical trials. Ligand- and antibody-targeted applications, designed to further increase site-specific delivery of liposomal drugs, are currently being explored in a number of laboratories.
Referência(s)